Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2005
06/01/2005EP1534674A2 Cytotoxic agents containing novel potent taxanes and their therapeutic use
06/01/2005EP1534391A1 Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
06/01/2005EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use
06/01/2005EP1534277A1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
06/01/2005EP1534276A2 Non-nucleoside reverse transcriptase inhibitors
06/01/2005EP1534275A1 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals
06/01/2005EP1534268A2 Tyrosine kinase inhibitors
06/01/2005EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents
06/01/2005EP1416936B1 Thiopyrane-4-ones as dna protein kinase inhibitors
06/01/2005EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
06/01/2005EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
06/01/2005EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors
06/01/2005EP0708756B1 Substituted 2-phenylpyridines with herbicidal action
06/01/2005CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
05/2005
05/31/2005US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents
05/31/2005US6900226 Quinoline and quinazoline derivatives; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity.
05/31/2005US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
05/31/2005US6900211 CCR5 antagonists useful for treating aids
05/31/2005US6900210 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
05/31/2005US6900196 Serine protease inhibitors
05/31/2005US6900194 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
05/31/2005CA2158275C Taxanes having an amino substituted side-chain
05/26/2005WO2005047282A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid
05/26/2005WO2005047273A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
05/26/2005WO2005047267A1 Process for the synthesis of imidazoles
05/26/2005WO2005047266A1 Aryl imidazoles and their use as anti-cancer agents
05/26/2005WO2005047258A2 Methods and compositions for selectin inhibition
05/26/2005WO2005047257A2 Methods and compositions for selectin inhibition
05/26/2005WO2005047255A1 Substituted nicotinoylcarbamates as pesticides
05/26/2005WO2005047250A1 N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders.
05/26/2005WO2005047247A1 Novel1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047246A1 Novel 1, 3-disubstituted azetidine deivatives for use as 5ht2a receptor ligands
05/26/2005WO2005047244A2 Inhibition of fgfr3 and treatment of multiple myeloma
05/26/2005WO2005046698A1 Fused heterocyclic compounds
05/26/2005WO2005046685A1 Substituted piperidines for the treatment of metabolic syndrome
05/26/2005WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/26/2005WO2005046604A2 Heteroaryl-hydrazone compounds
05/26/2005WO2005046590A2 Methods for synthesizing quinolinone compounds
05/26/2005WO2005046589A2 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
05/26/2005WO2005019168A8 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors
05/26/2005WO2004112719A8 Chemical compounds
05/26/2005US20050113566 Inhibitors of C-FMS kinase
05/26/2005US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid
05/26/2005US20050113438 Indolecarboxylic acid derivatives as plasminogen activator inhibitor inhibitors; anticoagulant, antiischemic, and anticarcinogenic agents; noninsulin-dependent diabetes, polycystic ovarian syndrome, cardiovascular disorders, atherosclerosis, alzheimer*s disease, chronic obstructive pulmonary disease
05/26/2005US20050113423 Modulators of ATP-binding cassette transporters
05/26/2005US20050113414 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens
05/26/2005US20050113399 Platelet ADP receptor inhibitors; ADP (adenosine 5'-diphosphate); thrombosis; contain thien-2-yl-sulfonylurea groups; 1-(thiophen-2-ylsulfonyl)-3-(4-(7-fluoro-6-(sec or tert-amino)-1-oxo-(3,4-dihydro)isoquinolin-2(1H)-yl)aryl)urea
05/26/2005US20050113396 Na+/H++exchanger-3 (NHE-3) inhibitors; antiischemic agents
05/26/2005US20050113387 Pyrazine derivatives and pharmaceutical use thereof
05/26/2005US20050113383 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
05/26/2005US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample
05/26/2005US20050113369 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
05/26/2005US20050113361 Amide derivatives as NMDA receptor antagonists
05/26/2005US20050113360 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one
05/26/2005US20050113359 NMDA (N-methyl-D-aspartate) receptors; eg 1-[4-(4-fluoro-benzyl)-piperidin-1-yl]-1-(6-hydroxy-1H-indole-2-yl)methanone
05/26/2005US20050113357 Cholinergic agents such as 3-[3-(4-methoxypiperidine)-1-yl-propyl]-1H-indole; for therapy of cognitive dysfunction, forgetfulness, confusion, memory loss, attention deficits, deficits in visual perception, depression, pain, sleep disorders, and psychosis
05/26/2005US20050113341 Stent with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
05/26/2005US20050113309 Useful as thrombin inhibitors
05/26/2005US20050112490 Electrophotographic organophotoreceptors with novel charge transport compounds
05/26/2005CA2545742A1 Process for the synthesis of imidazoles
05/26/2005CA2545373A1 Novel 1,3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands
05/26/2005CA2545350A1 Thiazole and pyrazole derivatives as flt-3 kinase inhibitors
05/26/2005CA2545340A1 Fused heterocyclic compounds
05/26/2005CA2545259A1 Heteroaryl-hydrazone compounds
05/26/2005CA2544693A1 Methods and compositions for selectin inhibition
05/26/2005CA2544492A1 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
05/26/2005CA2544186A1 Inhibition of fgfr3 and treatment of multiple myeloma with benzimidazole quinolinones
05/26/2005CA2543765A1 Methods and compositions for selectin inhibition
05/26/2005CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
05/25/2005EP1533310A1 Isonipecotamides for the treatment of integrin-mediated disorders
05/25/2005EP1533303A1 Substituted Aminosalicylacid Amides ( intermediates )
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532209A2 Charge transport compositions and electronic devices made with such compositions
05/25/2005EP1532140A1 Thienylhydrazon with digitalis-like properties ( positive inotropic effects )
05/25/2005EP1532136A1 Pyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532134A1 Novel thiophene acyl hydrazino derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
05/25/2005EP1532128A1 Inhibitors of hcv ns5b polymerase
05/25/2005EP1532120A1 Phenylpyridazine derivatives as ligands for gaba receptors
05/25/2005EP1532118A2 Imidazole compounds for the treatment of hepatitis c virus infections
05/25/2005EP1532113A2 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/25/2005EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid
05/25/2005EP1531824A2 Cyclothiocarbamative derivatives as pr modulators and use thereof for treatment of skin disorders
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531820A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
05/25/2005EP1531816A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1531811A2 Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer
05/25/2005EP1531674A2 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
05/25/2005EP1341742B1 Method for producing compounds having a cf2o bridge
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1064281B1 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
05/25/2005EP1056724B1 Substituted cycloalkyl-4-oxonicotinic carboxamides; gaba brain receptor ligands
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005DE10349587A1 Benzimidazolylderivate Benzimidazolylderivate
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620447A Isochroman compounds for treatment of cns disorders
05/25/2005CN1620439A Pancreatic lipase inhibitor compounds, their synthesis and use
05/25/2005CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
1 ... 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 ... 523